IEG Policy is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supplement industry, importers see advantages to FDA’s ORA alignment

This article is powered by Food Chemical News

A representative from the Council of Responsible Nutrition (CRN) and a consultant to importers said there's already evidence that the realignment of FDA's Office of Regulatory Affairs (ORA) is paying off.

Advertisement

Related Content

FDA’s ORA reorganization to be ‘stood up’ on May 15, but take years to be fully operational
FDA’s ORA reorganization to be ‘stood up’ on May 15, but take years to be fully operational
Hamburg releases ORA restructuring plan to make FDA ‘vertically-integrated’

Topics

What to read next

UsernamePublicRestriction

Register

PL214506

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel